Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801762 · ClinicalTrials.gov registry record
Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology
A clinical trial of Bladder Cancer, sponsored by Stanford University.
- Completed
- Registry status
- 195
- Enrollment target
- 1
- Study location
NCT00801762 is a study of Bladder Cancer that has completed, run by Stanford University. The registered enrollment target is 195 participants, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00801762, a study of Bladder Cancer, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 195 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to develop a novel approach to obtain real time optical biopsy of urinary tract pathology (e.g., bladder tumors) during urinary tract endoscopy using a novel fibered confocal microscope.
Conditions Studied
Interventions
- DEVICE Fibered confocal microscope
Study Locations (1)
California
- VA Palo Alto Health Care System - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2008-09 |
| Est. Completion | 2015-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00801762
The ClinicalTrials.gov registry entry for NCT00801762 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 1 intervention - of which Fibered confocal microscope is the first listed.
NCT00801762 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00801762 about?
NCT00801762 is a clinical study titled "Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology". The goal of the study is to develop a novel approach to obtain real time optical biopsy of urinary tract pathology (e.g., bladder tumors) during urinary tract endoscopy using a novel fibered confocal microscope.
What is the current status of trial NCT00801762?
This trial is currently completed. The enrollment target is 195 participants. The study started on 2008-09. Estimated completion is 2015-02.
What conditions does trial NCT00801762 study?
This clinical trial studies the following conditions: Bladder Cancer.
What interventions are being tested in trial NCT00801762?
The interventions under investigation include: Fibered confocal microscope (DEVICE).
Who is sponsoring clinical trial NCT00801762?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00801762 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RECRUITING · Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.